Advertisement

Role of Physical Activity, Exercise, and Cardiorespiratory Fitness in the Management of Resistant Hypertension

  • Puneet Narayan
  • Anubhav Kumar
Chapter

Abstract

Resistant hypertension (HTN) is defined as uncontrolled blood pressure ≥ 130/80 mm Hg despite treatment with adequate dosages of three or more antihypertensive medications, one of which is a diuretic or requiring a regimen of four or more medications for control. As is evident from the definition, controlling blood pressure is a challenge in this population. This lack of blood pressure control puts these patients at additional cardiovascular risk compared to the nonresistant hypertensive populations. It is well known and established that lowering blood pressure translates in lower risk of cardiovascular morbidity and mortality and is the cornerstone of the management of HTN. It is thus concerning that blood pressure-lowering trials in patients with resistant HTN have not uniformly translated in improved outcomes. This chapter will encompass definition of resistant HTN and factors that make blood pressure more resistant to treatment, together with the role of physical fitness, exercise, and cardiorespiratory fitness on lowering blood pressure, morbidity, and mortality in this subgroup of hypertensives.

Keywords

Resistant hypertension Cardiorespiratory fitness Physical activity Exercise Mortality HTN 

Abbreviations

ABPM

Ambulatory blood pressure monitor

BP

Blood pressure

CKD

Chronic kidney disease

CRF

Cardiorespiratory fitness

CVD

Cardiovascular disease

DM2

Type 2 diabetes mellitus

ETT

Exercise tolerance test

HIIT

High-intensity interval training

hs-CRP

High-sensitivity C-reactive protein

HTN

Hypertension

LVH

Left ventricular hypertrophy

METs

Metabolic equivalents

OSA

Obstructive sleep apnea

PA

Physical activity

PWV

Pulse wave velocity

References

  1. 1.
    Kagan A, Gordon T, Kannel WB, Dawber TR. Blood pressure and its relation to coronary heart disease in the Framingham study; hypertension volume VII. Drug action, epidemiology and hemodynamics. In: Proceedings of the Council for High Blood Pressure Research, American Heart Association. New York: American Heart Association; 1959. p. 53–81.Google Scholar
  2. 2.
    Principal Investigator, Freis E. Effects of treatment on morbidity and mortality in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA. 1970;213:1143–51.CrossRefGoogle Scholar
  3. 3.
    Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. J Am Coll Cardiol. 2017;71:2199.  https://doi.org/10.1016/j.jacc.2017.11.005.CrossRefPubMedGoogle Scholar
  4. 4.
    Pimenta E, Calhoun DA. Resistant hypertension: incidence, prevalence and prognosis. Circulation. 2012;125(13):1594–6.CrossRefGoogle Scholar
  5. 5.
    Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O'Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635–42.  https://doi.org/10.1161/CIRCULATIONAHA.111.068064. Epub 2012 Feb 29.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Smith SM, Huo T, Gong Y, Handberg E, Gulati M, Merz CN, Pepine CJ, Cooper-DeHoff RM. Mortality risk associated with resistant hypertension among women: analysis from three prospective cohorts encompassing the Spectrum of Women's heart disease. J Womens Health (Larchmt). 2016;25(10):996–1003.CrossRefGoogle Scholar
  7. 7.
    Sim JJ, Bhandari SK, Shi J, Reynolds K, Calhoun DA, Kalantar-Zadeh K, Jacobsen SJ. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and non-resistant hypertension. Kidney Int. 2015;88(3):622–32.CrossRefGoogle Scholar
  8. 8.
    Zhang J, Zhou S, Xua G. Carotid baroreceptor stimulation: a potential solution for resistant hypertension. Interv Neurol. 2014;2(3):118–22.CrossRefGoogle Scholar
  9. 9.
    Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Sidney A, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, for the SYMPLICITY HTN-3 investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–401.CrossRefGoogle Scholar
  10. 10.
    Ben-Sira D, Oliveira JMF. Hypertension in aging: physical activity as primary prevention. Eur Rev Aging Phys Act. 2007;4:85–9.CrossRefGoogle Scholar
  11. 11.
    Faselis C, Doumas M, Pittaras A, Narayan P, Myers J, Tsimploulis A, Kokkinos P. Exercise capacity and all-cause mortality in male veterans with hypertension aged ≥70 years. Hypertension. 2014;64:30–5.CrossRefGoogle Scholar
  12. 12.
    Williams B. The aorta and resistant hypertension. JACC. 2009;53(5):452–4.  https://doi.org/10.1016/j.jacc.2008.10.027.CrossRefPubMedGoogle Scholar
  13. 13.
    Pimenta E, Gaddam KK, Oparil S. Mechanisms and treatment of resistant hypertension. J Clin Hypertens. 2008;10(3):239–44.CrossRefGoogle Scholar
  14. 14.
    Meyer ML, Tanaka H, Palta P, et al. Correlates of segmental pulse wave velocity in older adults: the atherosclerosis risk in communities (ARIC) study. Am J Hypertens. 2016;29:114–22.CrossRefGoogle Scholar
  15. 15.
    McDonnell BJ, Maki-Petaja KM, Munnery M, Yasmin Wilkinson IB, Cockcroft JR, McEniery CM. Habitual exercise and blood pressure: age dependency and underlying mechanisms. Am J Hypertens. 2013;26(3):334–41.CrossRefGoogle Scholar
  16. 16.
    Kelley GA, Kelley KS. Progressive resistance exercise and resting blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2000;35:838–43.CrossRefGoogle Scholar
  17. 17.
    Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized control trials. Hypertension. 2001;38:1112–7.CrossRefGoogle Scholar
  18. 18.
    Hagberg JM, Park JJ, Brown MD. The role of exercise training in the treatment of hypertension: an update. Sports Med. 2000;30:193–206.CrossRefGoogle Scholar
  19. 19.
    Hamdorf PA, Penhall RK. Walking with its training effects on the fitness and activity patterns of 79-91 year old females. Aust NZ J Med. 1999;29:22–8.CrossRefGoogle Scholar
  20. 20.
    Brandão Rondon MU, Alves MJ, Braga AM, et al. Postexercise blood pressure reduction in elderly hypertensive patients. J Am Coll Cardiol. 2002;39:676–82.CrossRefGoogle Scholar
  21. 21.
    Kelley GA, Kelley KS. Aerobic exercise and resting blood pressure in older adults: a meta-analysis review of randomized controlled trials. J Gerontol Ser A Biol Med Sci. 2001;56:M298–303.CrossRefGoogle Scholar
  22. 22.
    Huang G, Thompson CJ, Osness WH. Influence of a 10-week controlled exercise program on resting blood pressure in sedentary older adults. J Appl Res. 2006;6:188–95.Google Scholar
  23. 23.
    Toth PP. Short-term aerobic exercise in the elderly promotes blood pressure reduction. J Appl Res. 2006;6:186–7.Google Scholar
  24. 24.
    Mancia G, Laurent S, Gabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens. 2009;27:2121–58.CrossRefGoogle Scholar
  25. 25.
    Kim J, Lee SK, Yoon DW, Shin C. Obstructive sleep apnoea is associated with progression of arterial stiffness independent of obesity in participants without hypertension: a KoGES prospective cohort study. Sci Rep. 2018;8(1):8152.  https://doi.org/10.1038/s41598-018-26587-y.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17(1):61–6.CrossRefGoogle Scholar
  27. 27.
    Khan A, Patel NK, O'Hearn DJ, Khan S. Resistant hypertension and obstructive sleep apnea. Int J Hypertens. 2013;2013:193010.CrossRefGoogle Scholar
  28. 28.
    Elias MF, Crichton GE, Dearborn PJ, Robbins MA, Abhayaratna WP. Associations between type 2 diabetes mellitus and arterial stiffness: a prospective analysis based on the maine-syracuse study. Pulse (Basel). 2018;5(1–4):88–98.  https://doi.org/10.1159/000479560.CrossRefGoogle Scholar
  29. 29.
    Devereux RB, Roamn MJ, Paraniacas M, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 2000;101:2271–6.CrossRefGoogle Scholar
  30. 30.
    Stewart KJ. Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health. JAMA. 2002;288(13):1622–31.CrossRefGoogle Scholar
  31. 31.
    Hayashino Y, Jackson JL, Fukumori N, Nakamura F, Fukuhara S. Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2012;98(3):349–60.  https://doi.org/10.1016/j.diabres.2012.10.004. Epub 2012 Oct 29.CrossRefPubMedGoogle Scholar
  32. 32.
    Fernando GF, Cardosa CRL, Fiszman R, Muxfeldt S. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension. Am Heart J. 2010;159(5):833–40.CrossRefGoogle Scholar
  33. 33.
    Kokkinos PF, Narayan P, Colleran JA, Pittaras A, Notargiacomo A, Reda D, Papademetrious V. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African American men with severe hypertension. N Engl J Med. 1995;333:1462–7.CrossRefGoogle Scholar
  34. 34.
    Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999;33:1004–10.CrossRefGoogle Scholar
  35. 35.
    Barcellos FC, Del Vecchio FB, Reges A, Mielke G, Santos IS, Umpierre D, Bohlke M, Hallal PC. Exercise in patients with hypertension and chronic kidney disease: a randomized controlled trial. J Hum Hypertens. 2018;32:397.  https://doi.org/10.1038/s41371-018-0055-0.CrossRefPubMedGoogle Scholar
  36. 36.
    Leehey DJ, Moinuddin I, Bast JP, Qureshi S, Jelinek CS, Cooper C, Edwards LC, Smith BM, Collins EG. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovasc Diabetol. 2009;8:62.  https://doi.org/10.1186/1475-2840-8-62.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Fritze O, Romero B, Schleicher M, et al. Age-related changes in the elastic tissue of the human aorta. J Vasc Res. 2012;49:77–86.CrossRefGoogle Scholar
  38. 38.
    Amento EP, Ehsani N, Palmer H, et al. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 1991;11:1223–30.CrossRefGoogle Scholar
  39. 39.
    The CAFE Investigators, CAFE Steering Committee and Writing Committee, Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O’Rourke M, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood pressure–lowering drugs on central aortic pressure and clinical outcomes. Principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113:1213–25.CrossRefGoogle Scholar
  40. 40.
    lachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.CrossRefGoogle Scholar
  41. 41.
    O’Rourke MF, Safar ME, Adji A. Resistant hypertension and central aortic pressure. J Hypertens. 2014;32(3):699–701.CrossRefGoogle Scholar
  42. 42.
    Ramosa JS, Dalleckb LC, Ramosc MV, Fabio Borranid F, Robertsa L, Gomersalla S, Beethama KS, Diasa KA, Keatinga SE, Fassetta RG, Sharmanf JF, Coombes JS. 12 min/week of high-intensity interval training reduces aortic reservoir pressure in individuals with metabolic syndrome: a randomized trial. J Hypertens. 2016;34:1977–87.CrossRefGoogle Scholar
  43. 43.
    Dimeo F, Pagonas N, Seibert F, Arndt R, Zidek W, Westhoff TH. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension. 2012;60:653–8.CrossRefGoogle Scholar
  44. 44.
    Guimaraes GV, de Barros Cruz LG, Fernandes-Silva MM, Dorea EL, Bocchi EA. Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: a randomized controlled trial (HEx trial). Int J Cardiol. 2014;172(2):434–41.  https://doi.org/10.1016/j.ijcard.2014.01.100. Epub 2014 Jan 24.CrossRefPubMedGoogle Scholar
  45. 45.
    Rossi A, Dikareva A, Bacon SL, Daskalopoulou SS. The impact of physical activity on mortality in patients with high blood pressure: a systematic review. J Hypertens. 2012;30(7):1277–88.CrossRefGoogle Scholar
  46. 46.
    Narayan P, Doumas M, Kumar A, Faselis CJ, Myers JN, Pittaras A, Kokkinos PF. Impact of cardiorespiratory fitness on mortality in black male veterans with resistant systemic hypertension. Am J Cardiol. 2017;120(9):1568–71.  https://doi.org/10.1016/j.amjcard.2017.07.055. Epub 2017 Jul 31.CrossRefPubMedGoogle Scholar
  47. 47.
    Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Puneet Narayan
    • 1
  • Anubhav Kumar
    • 1
  1. 1.Clinical Research Institute of Northern VirginiaBurkeUSA

Personalised recommendations